Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

NCT00107900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthroplasty, Replacement, Hip
Thrombosis

Interventions

DRUG: DU-176b

Sponsor

Daiichi Sankyo